Matthew Leinung
Overview
Explore the profile of Matthew Leinung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin H, Tang H, Leinung M, Mousa S, Hercbergs A, Davis P
Endocr Res
. 2019 Apr;
44(4):148-152.
PMID: 30943372
: Reverse T3 (rT3; 3,3',5'-triiodo-L-thyronine) is widely regarded as an inactive naturally occurring analog of thyroid hormone. rT3 is known to bind to the thyroid hormone analog receptor on plasma...
2.
Lin H, Chin Y, Shih Y, Chen Y, Leinung M, Keating K, et al.
Oncotarget
. 2018 Oct;
9(75):34033-34037.
PMID: 30344919
The PD-1/PD-L1 immune checkpoint involving tumor cells and host immune defense lymphocytes is a well-studied therapeutic target in oncology. That PD-1 and PD-L1 may have additional functions within tumor cells...
3.
Hercbergs A, Mousa S, Leinung M, Lin H, Davis P
Horm Cancer
. 2018 Feb;
9(3):139-143.
PMID: 29441459
There is preclinical and recent epidemiological evidence that thyroid hormone supports breast cancer. These observations raise the issue of whether management of breast cancer in certain settings should include consideration...
4.
Davis P, Leonard J, Lin H, Leinung M, Mousa S
Vitam Horm
. 2018 Feb;
106:67-96.
PMID: 29407448
Nongenomic actions of thyroid hormone are initiated by the hormone at receptors in the plasma membrane, in cytoplasm, or in mitochondria and do not require the interaction of nuclear thyroid...
5.
Ahmad S, Leinung M
Transgend Health
. 2017 Nov;
2(1):176-179.
PMID: 29159311
Transition from female to male gender after initiation of hormonal therapy involves both phenotypic and physiological changes. The response to treatment can vary widely from person to person. In this...
6.
Marchese M, Leinung M, Shawa H
Avicenna J Med
. 2017 May;
7(2):67-70.
PMID: 28469989
A 43-year-old incarcerated man with AIDS was hospitalized for 30 pounds weight loss and diffuse pruritic rash. Three months prior, he was started on dapsone for pneumonia prevention. Biochemical evaluation...
7.
Leinung M, Wu C
Endocr Pract
. 2017 Mar;
23(6):669-671.
PMID: 28332875
Objective: The biologic basis for gender identity is unknown. Research has shown that the ratio of the length of the second and fourth digits (2D:4D) in mammals is influenced by...
8.
Lin H, Chin Y, Nana A, Shih Y, Lai H, Tang H, et al.
Steroids
. 2016 May;
114:59-67.
PMID: 27221508
The PD-1 (programmed death-1)/PD-L1 (PD-ligand 1) checkpoint is a critical regulator of activated T cell-cancer cell interactions, defending tumor cells against immune destruction. Nano-diamino-tetrac (NDAT; Nanotetrac) is an anticancer/anti-angiogenic agent...
9.
10.
Leinung M, Nardacci E, Patel N, Bettadahalli S, Paika K, Thompson S
Diabetes Technol Ther
. 2013 Jun;
15(9):744-7.
PMID: 23786229
Background: The clinical utility of short-term professional continuous glucose monitoring (CGM) is uncertain. Subjects And Methods: This is a retrospective review of 121 consecutive insulin-treated patients seen in a university-based...